XML 41 R28.htm IDEA: XBRL DOCUMENT
v3.6.0.2

Selected Quarterly Financial Information | 12 Months Ended
--- | ---
Dec. 31, 2016
Selected Quarterly Financial Information [Abstract] |
Selected Quarterly Financial Information (Unaudited) | SELECTED QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (in thousands, except per share data) ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿ | First |  | Second |  | Third |  | Fourth |
﻿ | Quarter |  | Quarter |  | Quarter |  | Quarter |
﻿REVENUE: |  |  |  |  |  |  |  |  |  |  |  |
﻿2016 | $ | 43,016 | * | $ | 47,083 | * | $ | 45,252 | * | $ | 45,029 | *
﻿2015 |  | 33,831 |  |  | 35,526 |  |  | 36,703 |  |  | 39,838 |
﻿2014 |  | 35,731 |  |  | 34,690 |  |  | 37,069 |  |  | 37,151 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿GROSS MARGIN: |  |  |  |  |  |  |  |  |  |  |  |
﻿2016 | $ | 27,621 | * | $ | 30,301 | * | $ | 29,782 | * | $ | 31,195 | *
﻿2015 |  | 19,667 |  |  | 21,554 |  |  | 22,982 |  |  | 26,516 |
﻿2014 |  | 22,473 |  |  | 22,384 |  |  | 23,799 |  |  | 22,635 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿NET INCOME (LOSS): |  |  |  |  |  |  |  |  |  |  |  |
﻿2016 | $ | 2,541 | * | $ | 2,347 | * | $ | 2,993 | * | $ | 2,897 | *
﻿2015 |  | (274) |  |  | (502) |  |  | 2,145 |  |  | 2,636 |
﻿2014 |  | 1,059 |  |  | 2,161 |  |  | 2,326 |  |  | 1,776 |
﻿ |  |  |  |  |  |  |  |  |  |  |  |
﻿INCOME (LOSS) PER COMMON SHARE—DILUTED: |  |  |  |  |  |  |  |  |  |  |  |
﻿2016 | $ | 0.08 | * | $ | 0.07 | * | $ | 0.09 | * | $ | 0.09 | *
﻿2015 |  | (0.01) |  |  | (0.02) |  |  | 0.07 |  |  | 0.09 |
﻿2014 |  | 0.04 |  |  | 0.08 |  |  | 0.08 |  |  | 0.06 |
﻿ *In January 2016 the Company completed its acquisition of On-X Life Technologies Holdings, Inc., which is being operated as a wholly owned subsidiary of CryoLife. In 2016 the Company also sold its HeRO Graft product line and its ProCol product line, and ceased sales of these products during 2016. ﻿

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SelectedQuarterlyFinancialInformationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration